Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001708599-25-000124
Filing Date
2025-10-27
Accepted
2025-10-27 16:02:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFR14A serproxyamendment4925-3977.htm DEFR14A 23016
  Complete submission text file 0001708599-25-000124.txt   24146
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-38519 | Film No.: 251419872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)